371 related articles for article (PubMed ID: 28418877)
1. Transforming growth factor-β1 promotes breast cancer metastasis by downregulating miR-196a-3p expression.
Chen Y; Huang S; Wu B; Fang J; Zhu M; Sun L; Zhang L; Zhang Y; Sun M; Guo L; Wang S
Oncotarget; 2017 Jul; 8(30):49110-49122. PubMed ID: 28418877
[TBL] [Abstract][Full Text] [Related]
2. miR-629-3p may serve as a novel biomarker and potential therapeutic target for lung metastases of triple-negative breast cancer.
Wang J; Song C; Tang H; Zhang C; Tang J; Li X; Chen B; Xie X
Breast Cancer Res; 2017 Jun; 19(1):72. PubMed ID: 28629464
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-455-3p promotes invasion and migration in triple negative breast cancer by targeting tumor suppressor EI24.
Li Z; Meng Q; Pan A; Wu X; Cui J; Wang Y; Li L
Oncotarget; 2017 Mar; 8(12):19455-19466. PubMed ID: 28038450
[TBL] [Abstract][Full Text] [Related]
4. The pro-metastasis effect of circANKS1B in breast cancer.
Zeng K; He B; Yang BB; Xu T; Chen X; Xu M; Liu X; Sun H; Pan Y; Wang S
Mol Cancer; 2018 Nov; 17(1):160. PubMed ID: 30454010
[TBL] [Abstract][Full Text] [Related]
5. miR-331-3p Suppresses Cell Proliferation in TNBC Cells by Downregulating NRP2.
Zhao M; Zhang M; Tao Z; Cao J; Wang L; Hu X
Technol Cancer Res Treat; 2020; 19():1533033820905824. PubMed ID: 32174262
[TBL] [Abstract][Full Text] [Related]
6. TGFβ1 regulates HGF-induced cell migration and hepatocyte growth factor receptor MET expression via C-ets-1 and miR-128-3p in basal-like breast cancer.
Breunig C; Erdem N; Bott A; Greiwe JF; Reinz E; Bernhardt S; Giacomelli C; Wachter A; Kanthelhardt EJ; Beißbarth T; Vetter M; Wiemann S
Mol Oncol; 2018 Sep; 12(9):1447-1463. PubMed ID: 30004628
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia-inducible microRNA-224 promotes the cell growth, migration and invasion by directly targeting RASSF8 in gastric cancer.
He C; Wang L; Zhang J; Xu H
Mol Cancer; 2017 Feb; 16(1):35. PubMed ID: 28173803
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-409-3p regulates cell invasion and metastasis by targeting ZEB1 in breast cancer.
Ma Z; Li Y; Xu J; Ren Q; Yao J; Tian X
IUBMB Life; 2016 May; 68(5):394-402. PubMed ID: 27079864
[TBL] [Abstract][Full Text] [Related]
9. miR-199a-5p confers tumor-suppressive role in triple-negative breast cancer.
Chen J; Shin VY; Siu MT; Ho JC; Cheuk I; Kwong A
BMC Cancer; 2016 Nov; 16(1):887. PubMed ID: 27842518
[TBL] [Abstract][Full Text] [Related]
10. PTTG1 regulated by miR-146a-3p promotes bladder cancer migration, invasion, metastasis and growth.
Xiang W; Wu X; Huang C; Wang M; Zhao X; Luo G; Li Y; Jiang G; Xiao X; Zeng F
Oncotarget; 2017 Jan; 8(1):664-678. PubMed ID: 27893422
[TBL] [Abstract][Full Text] [Related]
11. miR-190 suppresses breast cancer metastasis by regulation of TGF-β-induced epithelial-mesenchymal transition.
Yu Y; Luo W; Yang ZJ; Chi JR; Li YR; Ding Y; Ge J; Wang X; Cao XC
Mol Cancer; 2018 Mar; 17(1):70. PubMed ID: 29510731
[TBL] [Abstract][Full Text] [Related]
12. Hsa-miR-1 suppresses breast cancer development by down-regulating K-ras and long non-coding RNA MALAT1.
Liu R; Li J; Lai Y; Liao Y; Liu R; Qiu W
Int J Biol Macromol; 2015 Nov; 81():491-7. PubMed ID: 26275461
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA LUCAT1/miR-5582-3p/TCF7L2 axis regulates breast cancer stemness via Wnt/β-catenin pathway.
Zheng A; Song X; Zhang L; Zhao L; Mao X; Wei M; Jin F
J Exp Clin Cancer Res; 2019 Jul; 38(1):305. PubMed ID: 31300015
[TBL] [Abstract][Full Text] [Related]
14. Zerumbone suppresses the motility and tumorigenecity of triple negative breast cancer cells via the inhibition of TGF-β1 signaling pathway.
Kim S; Lee J; Jeon M; Lee JE; Nam SJ
Oncotarget; 2016 Jan; 7(2):1544-58. PubMed ID: 26637807
[TBL] [Abstract][Full Text] [Related]
15. microRNA-761 induces aggressive phenotypes in triple-negative breast cancer cells by repressing TRIM29 expression.
Guo GC; Wang JX; Han ML; Zhang LP; Li L
Cell Oncol (Dordr); 2017 Apr; 40(2):157-166. PubMed ID: 28054302
[TBL] [Abstract][Full Text] [Related]
16. miR-105/93-3p promotes chemoresistance and circulating miR-105/93-3p acts as a diagnostic biomarker for triple negative breast cancer.
Li HY; Liang JL; Kuo YL; Lee HH; Calkins MJ; Chang HT; Lin FC; Chen YC; Hsu TI; Hsiao M; Ger LP; Lu PJ
Breast Cancer Res; 2017 Dec; 19(1):133. PubMed ID: 29258605
[TBL] [Abstract][Full Text] [Related]
17. miR-223-3p Inhibits Human Osteosarcoma Metastasis and Progression by Directly Targeting CDH6.
Ji Q; Xu X; Song Q; Xu Y; Tai Y; Goodman SB; Bi W; Xu M; Jiao S; Maloney WJ; Wang Y
Mol Ther; 2018 May; 26(5):1299-1312. PubMed ID: 29628305
[TBL] [Abstract][Full Text] [Related]
18. MiR-25-3p promotes the proliferation of triple negative breast cancer by targeting BTG2.
Chen H; Pan H; Qian Y; Zhou W; Liu X
Mol Cancer; 2018 Jan; 17(1):4. PubMed ID: 29310680
[TBL] [Abstract][Full Text] [Related]
19. miR-27b-3p suppresses cell proliferation through targeting receptor tyrosine kinase like orphan receptor 1 in gastric cancer.
Tao J; Zhi X; Zhang X; Fu M; Huang H; Fan Y; Guan W; Zou C
J Exp Clin Cancer Res; 2015 Nov; 34():139. PubMed ID: 26576539
[TBL] [Abstract][Full Text] [Related]
20. Regulation of cancerous progression and epithelial-mesenchymal transition by miR-34c-3p via modulation of MAP3K2 signaling in triple-negative breast cancer cells.
Wu J; Li WZ; Huang ML; Wei HL; Wang T; Fan J; Li NL; Ling R
Biochem Biophys Res Commun; 2017 Jan; 483(1):10-16. PubMed ID: 28069384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]